Qvar RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol is a breath-actuated inhaled prescription medicine used as a maintenance treatment for the prevention and control of asthma in ...

First and Only Breath-Actuated Aerosol Inhaled Corticosteroid in the United States Designed to Help Eliminate the Need for Hand-Breath Coordination JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical ...

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...

Objective: The aim of this study was to demonstrate that a new non-extra-fine metered-dose inhaler formulation of beclomethasone (beclomethasone dipropionate) containing hydrofluoroalkane (HFA) ...

Objective: To assess the bioequivalence of beclomethasone dipropionate (BDP) delivered from a press-and-breathe (PB) inhaler and a breath-actuated inhaler (Autohaler TM, AH). Design: Two randomised, ...

Please provide your email address to receive an email when new articles are posted on . Teva Pharmaceuticals announced that the FDA approved QVAR RediHaler inhalation aerosol for the prophylactic ...

In patients with mild asthma, mometasone furoate dry powder inhaler resulted in improved adherence and fewer exacerbations than beclomethasone dipropionate hydrofluoroalkane aerosol inhaler. Included ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of QVAR® (beclomethasone dipropionate ...

The FINANCIAL — Teva Pharmaceutical Industries Ltd. announced on August 7 that the U.S. Food and Drug Administration (FDA) has approved QVAR RediHaler (beclomethasone dipropionate HFA) inhalation ...

A total of 425 patients were included in both the modified intention-to-treat and safety analyses. ATLANTA, GA—Findings of a Phase 3 study (NCT02513160) presented at the 2017 AAAAI Annual Meeting ...

Please provide your email address to receive an email when new articles are posted on . Compared with a dual therapy inhaler, a triple therapy inhaler improved inspiratory capacity in those with COPD.